The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Adjuvant capecitabine for biliary tract cancer: The BILCAP randomized study.
 
John Neil Primrose
No Relationships to Disclose
 
Richard Fox
No Relationships to Disclose
 
Daniel H. Palmer
Honoraria - Bayer; BMS Brazil; Celgene; Nucana
Consulting or Advisory Role - Bayer; BMS Brazil; Celgene; Nucana
Research Funding - Bayer (Inst); Nucana (Inst)
 
Raj Prasad
No Relationships to Disclose
 
Darius Mirza
Honoraria - Covidien; Ethicon
Consulting or Advisory Role - Astellas Pharma; Novartis
Travel, Accommodations, Expenses - Astellas Pharma; Novartis
 
David Alan Anthoney
Consulting or Advisory Role - Novartis
 
Philippa Corrie
Consulting or Advisory Role - Baxalta; Bristol-Myers Squibb; Celgene; Merck Sharp & Dohme; Novartis; Roche
Research Funding - Novartis
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Sharp & Dohme
 
Stephen Falk
No Relationships to Disclose
 
Harpreet Singh Wasan
Honoraria - Array BioPharma; Celgene; Lilly; Merck KGaA; Servier; Sirtex Medical
Speakers' Bureau - Celgene; Merck KGaA; Sirtex Medical
Research Funding - Merck KGaA (Inst); Pfizer (Inst); Sirtex Medical (Inst)
 
Paul J. Ross
Honoraria - Bayer; Celgene; Merck Serono; Roche
Consulting or Advisory Role - Amgen; Baxalta; Bristol-Myers Squibb; Celgene; Sirtex Medical
Research Funding - Sanofi
Travel, Accommodations, Expenses - Amgen; Bayer; Celgene; Merck Serono; SERVIER
 
Lucy R. Wall
Research Funding - Amgen (Inst); AstraZeneca (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Bayer; Ipsen
Other Relationship - Novartis
 
Jonathan Wadsley
Honoraria - AstraZeneca; Bayer; Celgene; Eisai; Novartis
Consulting or Advisory Role - AstraZeneca; Bayer; Celgene; Eisai; Novartis
Speakers' Bureau - Eisai
Travel, Accommodations, Expenses - Celgene; Novartis; SOBI
 
T.R. Jeffry Evans
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Baxter (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Eisai (Inst); Karus Therapeutics (Inst)
Speakers' Bureau - Bristol-Myers Squibb
Research Funding - AstraZeneca (Inst); Basilea (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Daiichi Sankyo (Inst); Eisai (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Lilly (Inst); Merck (Inst); Roche (Inst); Verastem (Inst); Vertex (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Deborah Stocken
Research Funding - AstraZeneca (Inst)
 
Raaj Praseedom
No Relationships to Disclose
 
David Cunningham
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Celgene (Inst); MedImmune (Inst); Merck Serono (Inst); Merrimack (Inst); Sanofi (Inst)
 
O James Garden
Speakers' Bureau - Johnson & Johnson
 
Clive Stubbs
No Relationships to Disclose
 
Juan W. Valle
Consulting or Advisory Role - Agios; AstraZeneca; Baxalta; Delcath Systems; Ipsen; Lilly; Merck; Midatech Pharma; Novartis; Pfizer
Speakers' Bureau - Celgene; Novartis; Pfizer
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Lilly; Novartis
 
John A. Bridgewater
Honoraria - Merck Serono; SERVIER
Consulting or Advisory Role - Merck Serono; Roche; SERVIER
Speakers' Bureau - Celgene
Travel, Accommodations, Expenses - Merck Serono; MSD Oncology; SERVIER